ReviewFood science and biotechnology2025
Microbial exopolysaccharides as a sustainable food ingredient and their health benefits.
Review in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fermentation-A Potential Game Changer in the Development of Plant-Based Cream Cheese Alternatives.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many studies focus on regulating gut microbiota dysbiosis using beneficial bacteria, and postbiotics, particularly microbial exopolysaccharides (EPSs), are notable for their stability and potential in functional foods. EPSs are valued for their diverse structural properties and significant health benefits, especially for gut health. They are utilized as applications across various industries, including food, pharmaceuticals, biomedicine, and environmental management. However, the commercialization of EPSs requires extensive research into factors such as stability in different environments, interactions with biological fluids and enzymes, degradation profiles, and effects within living systems. This review provides an overview of different types of EPSs among postbiotics, highlighting their health benefits and discussing the considerations and limitations associated with their commercialization. Overall, the potential of microbial EPSs as functional food ingredients presents a promising opportunity for enhancing gut health and overall well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.